BioCentury
ARTICLE | Clinical News

EP217609: Phase I data

May 10, 2010 7:00 AM UTC

In a Phase I trial in 24 healthy volunteers, single-ascending doses of EP217609 were well tolerated and led to dose-dependent increases in both standard and specific coagulation tests. Endotis has rig...